Cartier F[au] - Search Results

Year	Number of Results
1946	1
1951	1
1953	1
1961	3
1962	1
1963	4
1964	6
1965	5
1966	5
1967	2
1968	2
1971	3
1972	3
1973	3
1974	4
1975	3
1976	1
1977	4
1978	3
1979	3
1980	3
1981	2
1982	3
1984	2
1986	3
1987	3
1988	2
1989	2
1990	3
1991	1
1992	2
1993	2
1994	1
1995	2
1996	4
1997	4
1998	4
1999	3
2000	2
2001	2
2013	1
2014	1
2015	1
2017	1
2019	1
2020	3
2022	0

1

Arterial hypertension.

CARTIER F. CARTIER F. J Am Inst Homeopath. 1946 Sep;39:299-302. J Am Inst Homeopath. 1946. PMID: 20996052 Free article. No abstract available.

2

Solvation effects drive the selectivity in Diels-Alder reaction under hyperbaric conditions.

Loco D, Spezia R, Cartier F, Chataigner I, Piquemal JP. Loco D, et al. Among authors: cartier f. Chem Commun (Camb). 2020 Jun 18;56(49):6632-6635. doi: 10.1039/d0cc01938k. Chem Commun (Camb). 2020. PMID: 32432613

3

miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.

Ghousein A, Mosca N, Cartier F, Charpentier J, Dupuy JW, Raymond AA, Bioulac-Sage P, Grosset CF. Ghousein A, et al. Among authors: cartier f. Liver Int. 2020 Jan;40(1):240-251. doi: 10.1111/liv.14276. Epub 2019 Oct 31. Liver Int. 2020. PMID: 31612616

4

[Tetanus].

Cartier F. Cartier F. Rev Infirm Assist Soc. 1966 Jun;16(6):513-8. Rev Infirm Assist Soc. 1966. PMID: 4160624 French. No abstract available.

5

New tumor suppressor microRNAs target glypican-3 in human liver cancer.

Cartier F, Indersie E, Lesjean S, Charpentier J, Hooks KB, Ghousein A, Desplat A, Dugot-Senant N, Trézéguet V, Sagliocco F, Hagedorn M, Grosset CF. Cartier F, et al. Oncotarget. 2017 Jun 20;8(25):41211-41226. doi: 10.18632/oncotarget.17162. Oncotarget. 2017. PMID: 28476031 Free PMC article.

6

Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers.

Talarmin C, Kerob S, Cartier F, Madelaine I, Mukenyi S, Schwartz E, Boissel N, Baruchel A, Thieblemont C, Parquet N, Brignier A, Lesprit E, Desproges A, Magdelonnette L, Larghero J, Mebarki M. Talarmin C, et al. Among authors: cartier f. Cytotherapy. 2020 Dec;22(12):792-801. doi: 10.1016/j.jcyt.2020.06.009. Epub 2020 Jul 27. Cytotherapy. 2020. PMID: 32732084

7

Physicochemical and microbiological stability of azathioprine in InOrpha suspending agent studied under various conditions.

Amin A, Bourget P, Vidal F, Cartier F, Beauvais R, Afonso Vdo N. Amin A, et al. Among authors: cartier f. Int J Pharm Compd. 2015 Jan-Feb;19(1):73-7. Int J Pharm Compd. 2015. PMID: 25902631

8

The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection.

Cartier F, Marcq I, Douam F, Ossart C, Regnier A, Debuysscher V, Lavillette D, Bouhlal H. Cartier F, et al. PLoS One. 2014 Jun 13;9(6):e99601. doi: 10.1371/journal.pone.0099601. eCollection 2014. PLoS One. 2014. PMID: 24927415 Free PMC article.

9

Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.

Marcq I, Nyga R, Cartier F, Amrathlal RS, Ossart C, Ouled-Haddou H, Ghamlouch H, Galmiche A, Chatelain D, Lamotte L, Debuysscher V, Fuentes V, Nguyen-Khac E, Regimbeau JM, Marolleau JP, Latour S, Bouhlal H. Marcq I, et al. Among authors: cartier f. PLoS One. 2013 Dec 20;8(12):e82918. doi: 10.1371/journal.pone.0082918. eCollection 2013. PLoS One. 2013. PMID: 24376606 Free PMC article.

10

Inhibition of intracellular growth of Listeria monocytogenes by antibiotics.

Michelet C, Avril JL, Cartier F, Berche P. Michelet C, et al. Among authors: cartier f. Antimicrob Agents Chemother. 1994 Mar;38(3):438-46. doi: 10.1128/AAC.38.3.438. Antimicrob Agents Chemother. 1994. PMID: 8203836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results